Gelatinase matrix metalloproteinase (MMP)-2 and MMP-9 of the umbilical cord blood in preeclampsia

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 4, 2008, Pages 517-522

  Galewska, Zofia ^a   Romanowicz, Lech ^a   Jaworski, Stefan ^a   Bańkowski, Edward ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Gelatinases; Metalloproteinases; Preeclampsia; Umbilical blood plasma; Umbilical blood serum

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; NEWBORN; PREECLAMPSIA; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; WESTERN BLOTTING; ZYMOGRAPHY;

ADULT; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEINS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HUMANS; IMMUNOASSAY; INFANT, NEWBORN; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PRE-ECLAMPSIA; PREGNANCY;

EID: 44949218488     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.083     Document Type: Article

References (27)

1. Jacob MP, Badier-Commander C, Fontaine V, Benazzoug Y, Feldman L, Michel JB. Extracellular matrix remodeling in the vascular wall. Pathol Biol 2001;49:326-32.
2. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
3. Gibbson GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994;330:1431-8.
4. Godin D, Ivan E, Johnson C, Magid R, Galis ZS. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 2000;102:249-55.
5. Myers JE, Merchant SJ, Macleod M, Mires GJ, Baker PN, Davidge ST. MMP-2 levels are elevated in the plasma of women who subsequently develop preeclampsia. Hypertens Pregnancy 2005;24:103-15.
6. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999;274:21491-4.
7. Rippman ET, editor. Gestosis index. Basel: Sandoz, 1971.
8. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-99.
9. Mannello F, Luchetti F, Canonico B, Falcieri E, Papa S. Measurements, zymographic analysis, and characterization of matrix metalloproteinase-2 and -9 in healthy human umbilical cord blood. Clin Chem 2004;50:1715-7.
10. Herron GS, Banda MJ, Clark EJ, Gavrlovic J, Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 1986;261:2814-8.
11. Unemori EN, Werb Z. Reorganization of polimerized actin: a possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J Cell Biol 1986;103:1021-31.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
13. Das SK, Yano SY, Wang J, Edwards DR, Nagase H, Dey SK. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. Dev Genet 1997;21:44-54.
14. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-22.
15. Lambert V, Munaut C, Jost M, Noel A, Werb Z, Foidart JM, et al. Matrix metalloproteinase-9 contributes to choroidal neovascularisation. Am J Pathol 2002;161:1247-53.
16. Elkington PT, O'Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 2005;142:12-20.
17. Bańkowski E, Romanowicz L, Jaworski S. Collagen of umbilical cord arteries and its alterations in EPH gestosis. J Perinat Med 1993;21:491-8.
18. Romanowicz L, Bańkowski E, Jaworski S, Chyczewski L. Glycosaminoglycans of umbilical cord arteries and their alterations in EPH gestosis. Folia Histochem Cytobiol 1994;32:199-204.
19. Bańkowski E, Sobolewski K, Romanowicz L, Chyczewski L, Jaworski S. Collagen and glycosaminoglycans of Wharton's jelly and their alterations in EPH-gestosis. Eur J Obstet Gynecol Reprod Biol 1996;66:109-17.
20. Dahiya R, Ganguli NK, Mayumdar S, Charkavarti RN. Aortal collagen polymorphism in monkey and man. J Biosci 1984;6:107-13.
21. Galewska Z, Bańkowski E, Romanowicz L, Jaworski S. Pre-eclampsia (EPH-gestosis)-induced decrease of MMP-s content in the umbilical cord artery. Clin Chim Acta 2003;335:109-15.
22. Tayebjee M, Karalis I, Nadar SK, Beevers G, MacFadyen RJ, Lip GY. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 and -2 levels in gestational hypertension. Am J Hypertens 2005;18:325-9.
23. Johnatty RM, Taub DD, Reeder SP, Turcovski-Corrales SM, Cottam DW, Stephenson TJ, et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997;158:2327-33.
24. Daniels JT, Schultz GS, Blalock TD, Garrett Q, Grotendorst GR, Dean NM, et al. Mediation of transforming growth factor-β1-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol 2003;163:2043-52.
25. Robak E, Wierzbowska A, Chmiela M, Kulczycka L, Sysa-Jȩdrejowska A, Robak T. Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythematosus. Mediators Inflamm 2006;1:1-7.
26. Schonherr E, Hausser HJ. Extracellular matrix and cytokines: a functional unit. Dev Immunol 2000;7:89-101.
27. Lanone S, Zheng T, Zhu Z, Liu W, Lee CG, Ma B, et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Incest 2002;110:463-74.